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ἓν οἶδα ὅτι οὐδὲν οἶδα 
The more I learn, the more I learn how little I know. -- Socrates  
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ABSTRACT 
Many cellular processes are dependent on the activation of G protein-coupled 
receptors (GPCRs). The development of drugs that can specifically target GPCRs 
and their corresponding signalling cascades is of high interest. Today, almost 
1000 different GPCRs are known and even though about 40 % of all prescribed 
pharmaceuticals on the market target GPCRs either directly or indirectly, only a 
small fraction of receptors are druggable. 
One specific Class of GPCRs are Frizzled (FZD), which belong to the Class F of 
GPCRs. Nineteen mammalian WNTs can bind to 10 FZDs in various 
combinations resulting in the activation of different downstream pathways 
such as WNT/β-catenin, WNT/planar cell polarity and WNT/Ca2+. These 
signaling pathways are highly involved in cell polarity, embryonic development, 
formation of neural synapses, cell proliferation, differentiation and many other 
processes in developing and adult organisms. Mutations and/or misregulation 
within the pathways are linked to many diseases ranging from cancer, 
inflammatory diseases to metabolic and neurological disorders. Therefore, 
targeting WNT receptors pharmacologically would be advantageous. Currently 
very little is known in regard to structure and precise function of Class Frizzled 
receptors. Particular the link between FZDs and heterotrimeric G proteins is a 
matter of discussion in the field. Furthermore, the lack of high throughput 
screening assays hampers the development of small compounds targeting FZDs. 
This thesis provides advanced insight into structural and functional aspects of 
WNT receptors with the focus on FZD6, from which not only future research but 
also drug discovery could benefit from. In addition, this thesis intends to 
provide novel tools to study this unconventinal class of receptors, which will 
allow extending the knowledge to the entire Class F and possible to other 
GPCRs. 
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1 INTRODUCTION 
Cells are spatially defined by a plasma membrane that serves as a border 
between the cell interior and the surrounding environment. Exterior signals are 
detected by receptors embedded in the cell membrane and the encoding 
information is transferred into the cell interior. Such signal transduction can be 
accomplished in various ways. The majority of receptors for hormones and 
neurotransmitters mediate the signal to effector proteins  located inside of the 
cell via the activation of heterotrimeric GTP-binding proteins (Gilman 1987, 
Dijksterhuis, Petersen et al. 2014). The superfamily of G protein-coupled 
receptors (GPCR) belongs to the largest protein-coding gene family in 
humans (McPherson, Marra et al. 2001). Almost 1000 various GPCRs have been 
identified to date. Their ligands range from biogenic amines, peptides, 
glycoproteins, lipids, nucleotides, to ions and proteases. GPCRs thus participate 
in innumerable physiological functions and even sensing exogenous stimuli such 
as taste, smell and light perception are mediated by this receptor family. GPCRs 
are divided into different classes based on their sequence homology and 
functional similarity. The first classification scheme that has been proposed for 
GPCRs divided them, on the basic of sequence homology, into six classes: 
Class A (rhodopsin-like), Class B (secretin receptor family), Class C 
(metabotropic glutamate), Class D (fungal mating pheromone receptors), Class 
E (cyclic AMP receptors) and Class F (frizzled/smoothened). Out of these, only 
classes D and E are not found in vertebrates (Kolakowski 1994). 
An alternative classification scheme called "GRAFS" divides vertebrate GPCRs 
into five classes (Glutamate, Rhodopsin, Adhesion, Frizzled/Taste2, Secretin) 
(Schioth and Fredriksson 2005, Bjarnadottir, Gloriam et al. 2006). 
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Furthermore, the International Union of Basic and Clinical Pharmacology 
(IUPHAR) published a concise guide for the nomenclature of GPCRs which I will 
use in this thesis (Alexander, Benson et al. 2013). 
The largest class by far is the rhodopsin-like receptor (Class A), which accounts 
for nearly 85 % of the GPCR genes. Frizzleds (FZDs) form a significantly smaller 
group, consisting of 10 FZDs and Smoothened (SMO) that are known to be 
seven-pass membrane proteins with receptor function. Despite the small size of 
this group, the complexity is demonstrated by the fact, that 10 FZDs can be 
activated by various ligands from the wingless/int (WNT) protein family 
consisting of 19 different members. Any combination between WNTs and FZDs, 
and thus their activation, is theoretically possible. 
However, very little is known about the specificity and selectivity between 
different WNTs and FZDs (Schulte 2010). 
WNT signaling pathways have been extensively studied and they are known to 
be crucial for cell-to-cell communication, differentiation, and morphogenesis 
during embryonic development and later in adulthood. Not surprisingly, the 
deregulation of WNT signaling is manifested in a high number of developmental 
defects, inherited diseases, and many types of cancer (Clevers 2006). 
Even though FZDs consist of seven trans-membrane domains and according to 
the International Union of Basic and Clinical Pharmacology are classified as a 
group of GPCRs, it is still a matter of debate if FZDs indeed signal through 
heterotrimeric G proteins in a physiologically relevant manner. 
This thesis aims to give a more detailed understanding of WNT receptors with a 
strong emphasis on FZD6 by investigating the receptor within the cell 
membrane itself and combine these findings with the mechanism, which 
underlie binding of WNTs to FZDs and subsequent signal initiation.   
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1.1 THE WORLD OF G PROTEIN-COUPLED RECEPTORS 
The very first explicit postulation for the existence of membrane-embedded 
receptors goes back to the British pharmacologist J. N. Langley. He wrote in 
1905:  
”I conclude then that in all cells two constituents at least must be 
distinguished, 1) substance concerned with carrying out the chief functions of 
the cells, such as contraction, secretion, the formation of special metabolic 
products, and 2) receptive substances especially liable to change and capable 
of setting the chief substance in action.” (Langley 1905) 
Langley postulated two very important functions of these hypothetical 
receptor structures: 1) They react on chemical substances and stimuli 
probably due to specific binding and 2) they operate on effectors within the 
cell and can alter their function. 
Since then time has passed and many researchers have questioned Langley. 
However, the work on GPCRs became so important and valuable that two 
Nobel Prizes were awarded so far in this research area. Alfred G. Gilman and 
Martin Rodbell were given in 1994 the Nobel Prize in medicine "for their 
discovery of G proteins and the role of these proteins in signal transduction in 
cells". Eighteen years later, in 2012, Robert Lefkowitz and Brian K. Kobilka were 
awarded the Nobel Prize in Chemistry "for their studies of G protein–coupled 
receptors". 
But what is so special about these GPCRs? 
GPCRs are composed of seven transmembrane helices. The binding sites for 
small and medium ligands are located in the membrane interior and for larger 
ligands rather in the extracellular regions of the receptor. 
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The N-terminus is extracellular and the C-terminal end is 
localized inside the cell. A disulfide bridge, which covalently connects the first 
and second intracellular loop is conserved in many GPCRs. Due to 
sequence homologies within the seven trans-membrane-domains (7TMD), 
GPCRs can be divided into different classes as mentioned previously 
(Kolakowski 1994, Schioth and Fredriksson 2005, Bjarnadottir, Gloriam et al. 
2006, Alexander, Benson et al. 2013). 
When a ligand binds to its receptor, the binding site to G proteins is exposed by 
a conformational transition. Once the association of an active ligand-receptor 
complex is achieved, it subsequently leads to a ligand-receptor-G protein 
complex and the initiation of a signal cascade (Kobilka 2007). 
While the function of classical GPCRs is already fairly well understood, FZDs are 
one of the less studied family of GPCRs (Schulte 2010). 
1.1.1 Discovery of the Frizzled Class of receptors 
The so-called frizzled gene was first identified in Drosophila melanogaster in a 
screen for mutations that disrupt the polarity of epidermal cells in the adult fly 
(Wang, Macke et al. 1996). The discovered and responsible pathway – known as 
Planar Cell Polarity (PCP) - is key for the proper development of tissue polarity 
and has been identified in the 1980s (Vinson, Conover et al. 1989, Slusarski, 
Corces et al. 1997, Strutt, Weber et al. 1997, Gubb, Green et al. 1999). Key 
members of the PCP pathway are FZDs (Vinson, Conover et al. 1989), 
Dishevelled (Slusarski, Corces et al. 1997), Van Gogh (Vang) (Taylor, Abramova 
et al. 1998) and starry night (also known as Flamingo) (Chae, Kim et al. 1999). 
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FZDs can be found in a vast variety of organisms ranging from humans over 
Drosophila melanogaster, Caenorhabditis elegans to sponge Suberites 
domuncula (Adell, Nefkens et al. 2003) and Hydra vulgaris (Minobe, Fei et al. 
2000). 
Ten isoforms of FZDs can be found in vertebrates, four in Drosophila 
melanogaster and three in Caenorhabditis elegans (Huang and Klein 2004). 
All vertebrate isoforms can be divided into four main clusters based on their 
homology (Fredriksson, Lagerstrom et al. 2003). FZD1, FZD2 and FZD7 form the 
first cluster sharing approximately 75 % identity whereas the second group 
formed by FZD5 and FZD8 share 70 %. The third cluster comprised by FZD4, FZD9 
and FZD10 share 65 % and the last cluster (FZD3 and FZD6) share 50 % amino acid 
identity. All FZD genes from different clusters share between 20 % and 40 % 
sequence similarity. 
FZDs are bound and activated by the lipoglycoproteins of the WNT family 
(Willert, Brown et al. 2003; Schulte, 2010). However, expect of WNTs other 
molecules have been described to bind and activate FZDs. For example, Norrin 
– a protein that in humans is encoded by the NDP gene – was shown to bind 
and activate FZD4 to subsequently induce -catenin stabilization (Niehrs 2004, 
Xu, Wang et al. 2004). Dickkopf (DKK), Wise/Sclerostin and WNT inhibitory 
factor (WIFs) have been shown to be upregulated, when WNT signaling is 
activated, therefore antagonizing it (Niehrs 2006, MacDonald, Tamai et al. 
2009, Cruciat and Niehrs 2013). Soluble Frizzled-related proteins (SFRPs) 
contain a FZD-like cysteine rich domain, which can bind and sequester WNTs 
(Hsieh, Rattner et al. 1999, Jones and Jomary 2002). However, SFRPs under 
certain circumstances, also bind and activate Frizzled receptors  (Bovolenta, 
Esteve et al. 2008). 
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Furthermore, R-spondin is known to act through leucine-rich repeat-containing 
G protein-coupled receptors (LGRs) thereby sensitizing cells to WNT responses 
(Carmon, Gong et al. 2011). 
Every receptor in the FZD family has a signal sequence in the very end of the 
extracellular N-terminal that is required for adequate insertion of the protein 
into the membrane. This signaling sequence is followed by a cysteine-rich 
domain (CRD), which is the orthosteric ligand binding site that binds WNTs 
(Dann, Hsieh et al. 2001, Janda, Waghray et al. 2012) 
1.1.2 The WNT family 
The first member of the WNT ligand family was int1, which was discovered in 
mouse, where it was activated as a proto-oncogene by the integration of the 
mouse mammary tumor virus (MMTV), leading to the development of breast 
cancer (Nusse and Varmus 1982). With the identification of Wingless (wg), the 
WNT1 ortholog in Drosophila melanogaster (Cabrera, Martinez-Arias et al. 
1987, Rijsewijk, Schuermann et al. 1987), it became clear that WNT genes are 
also significantly involved in embryonic development (Nusse and Varmus 1992). 
Their mutations were shown to contribute to disturbances in the wings 
architecture as well as in the segment polarity (Sharma, Sharma et al. 1973, 
Nusslein-Volhard and Wieschaus 1980). The term "WNT" originated from the 
fusion of "Wingless" and "Integration 1" (Nusse and Varmus 1992). 
WNT proteins not only play a key role in the regulation of various stages of 
embryonic development, such as the creation of patterning, but they are also 
involved in controlling the differentiation, proliferation, invasion, polarity and 
apoptosis of cells (Miller 2002). In adulthood, disturbances of the WNT signaling 
pathways can cause various diseases such as many types of cancer (Polakis 
2000), osteoporosis (Patel and Karsenty 2002) and many others. 
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The human WNT family comprises of 19 different members that appear highly 
conserved in a variety of organisms. 
WNTs are secreted as lipid modified glycoproteins, which have a length of 350 
to 400 amino acids (aa). Other characteristic features of WNTs include a signal 
sequence for their secretion, a few highly charged residues and a large number 
of N-linked glycosylation sites (Willert, Brown et al. 2003). In addition, WNT 
proteins are characterized by a highly conserved distribution of 23 cysteines. 
In addition to the classification of WNTs due to their amino acid sequence 
homology (Miller 2002), a further classification of the WNTs has been 
established considering the ability of individual WNTs to induce the 
transformation of murine mammary gland cells (C57MG) and thus cause breast 
cancer (Wong, Gavin et al. 1994, Polakis 2000). Members, which cause a strong 
transformation, were WNT-1, WNT-3, WNT-3A and WNT-7A. Little or no 
transformative causing WNTs were WNT-2, WNT-4, WNT-5A, WNT-5B, WNT-6, 
WNT-7B and WNT-11 (Kikuchi and Yamamoto 2007, Kikuchi, Yamamoto et al. 
2007). 
Historically, WNT-induced signaling has been classified into “canonical WNT 
signaling” and "non-canonical WNT signaling" based on the involvement 
ofcatenin. However, this classification is no longer retained since it was 
shown that canonical WNT-3A is also able to induce β-catenin independent 
signaling through the activation of Rho and Rho kinases (Kuhl, Sheldahl et al. 
2000) or G proteins (Halleskog and Schulte 2013). Moreover, under certain 
conditions, WNT-5A (previously classified as “non-canonical WNT”) can induce 
both β-catenin dependent as well as β-catenin-independent pathways (Mikels 
and Nusse 2006). 
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1.1.3 WNT/FZD signaling 
In general, there are at least three different branches of WNT signaling 
pathways described in the literature. The rather well-studied -catenin-
dependent WNT/β-catenin signaling pathway, as well as -catenin-independent 
WNT/PCP (planar cell polarity) - and WNT/Ca2+ signaling pathway, which have 
been extensively studied in Drosophila and Xenopus. However, little is known 
about their biological function in mammals. 
The WNT/PCP pathway is known to control cell polarity and cell movements 
during gastrulation (Heisenberg, Tada et al. 2000) and especially FZD3 and FZD6 
seem to have a major role in neural tube closure and in the planar polarity of 
inner-ear sensory hair cells (Wang, Guo et al. 2006). 
WNT/PCP-signaling leads to intracellular polarization of proteins such as 
Dishevelled (DVL), Prickle and Vangl, resulting in activation of small GTPases 
such as Rho and Rac, and consequently in oriented alignment of the 
cytoskeleton filaments. 
The WNT/Ca2+ signaling pathway has been linked to an increase in intracellular 
Ca2+ concentration through heterotrimeric G protein activated phospholipase C 
and phosphodiesterase (Slusarski, Corces et al. 1997, Ahumada, Slusarski et al. 
2002). The intracellular Ca2+ increase leads to a further activation of 
calcium/calmodulin-dependent protein kinase II (CaMKII), and the protein 
kinase C (Kuhl, Sheldahl et al. 2000). Although their importance is not fully 
understood yet, a function for cell proliferation and migration is suspected 
(Kuhl, Sheldahl et al. 2000). 
Further function of the WNT/Ca2+ signaling pathway appears to be the 
inhibition of the WNT/β-catenin signaling pathway. 
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Here, the CamKII- and TAK1-mediated activation of mitogen-activated protein 
kinase NLK (NLK-MAPK), phosphorylates the T-cell factor (TCF), and thereby 
inhibits the binding of the β-catenin/TCF complex to the DNA and thus prevents 
the transcription (Ishitani, Kishida et al. 2003). 
In the context of heterotrimeric G proteins, it was reported that WNT-5A 
induces G protein-dependent signaling to ERK1/2 and WNT-5A was linked to 
the regulation of proinflammatory responses in mouse primary microglia cells 
(Halleskog, Dijksterhuis et al. 2012). 
1.1.4 Frizzled 6 
Historically, FZD6 has been linked to the PCP pathway, where it is important for 
the proper orientation of hair follicles (Wang, Badea et al. 2006), auditory 
sensory cells and for neural tube closure (Wang, Guo et al. 2006). Furthermore, 
it has been shown that FZD6 negatively regulates the -catenin dependent 
pathway (Golan, Yaniv et al. 2004). Despite a positive correlation between FZD6 
expression and WNT-3A induced β-catenin activation in human mesenchymal 
stem cells was shown, the knockdown of FZD6 in these cells had no influence on 
this activation (Kolben, Perobner et al. 2012). 
Lately it has been shown that mutation of FZD6 can result in defects in nail and 
claw formation. The mutated form of FZD6 shows abolished membranous levels 
and nonfunctional WNT/FZD signaling in mammals (Frojmark, Schuster et al. 
2011). In this context it is not surprising that FZD6 deficiency disrupts the 
differentiation process of nail development (Cui, Klar et al. 2013). Furthermore, 
FZD6 is a critical component linked to the development of B cell lymphocytic 
leukemia (Wu, Zierold et al. 2009). 
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For the purpose of this thesis it is important to mention that FZD6 is highly 
expressed in the lung epithelium and leads to cancer once miss-regulated 
occurs  (van Helden, Godschalk et al. 2010, Piga, van Dartel et al. 2014) 1. 
Using a mono color FRAP approach, our group has previously analyzed the 
WNT-isoform-specific abilities to promote changes in FZD6 molecular mobility 
and grouped them accordingly. Among the WNTs tested, fast and transient 
mobility shifters were: WNT-2B and WNT-7A. Intermediate and transient 
shifters were: WNT-1, WNT-5A, WNT-9B and WNT-10B and slow and persistent 
shifters were WNT-3A and WNT-4. WNT-5B and WNT-11 did not show any 
affect in the molecular mobility upon stimulation (Kilander, Dahlstrom et al. 
2014).  
Most interestingly, with the use of pertussis toxin and pertussis toxin-resistant 
mutants of Gi, the study linked the change in mobility shift to the dissociation 
of the heterotrimeric G protein (in case of WNT-5A) (Kilander, Dahlstrom et al. 
2014). 
1.1.5 Other WNT receptors: LRP5/6, ROR1/2, Vangl1/2 and RYK 
In addition to FZDs, other membrane receptors have been associated with WNT 
signaling, which I will describe only briefly: 
1.1.5.1 LRP5/6: 
The low-density lipoprotein-related proteins 5 and 6 (LRP5 and LRP6) belong to 
the type I transmembrane proteins with a single membrane spanning domain 
and play an essential role in the signal transduction of WNT/-catenin signaling 
(Pinson, Brennan et al. 2000). 
                                                 
1
 http://www.proteinatlas.org/ENSG00000164930-FZD6/cancer/tissue/lung+cancer 
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The extracellular N-terminus of LRP5/6 represents the main part of the protein 
(He, Semenov et al. 2004), and an interaction of this domain with various WNT 
proteins was experimentally be detected. WNT-1 and WNT-4 were shown to 
bind LRP5 (Mao, Wang et al. 2001, Kato, Patel et al. 2002), whereas WNT-1, 
WNT-3A, WNT-9B and XWNT-8 show preferential binding to LRP6 (Itasaki, Jones 
et al. 2003, Liu, Bafico et al. 2003, Tamai, Zeng et al. 2004, Bourhis, Tam et al. 
2010). However, the WNT/LRP5/6 interaction seems to be significantly weaker 
compared to WNT/FZD binding (He, Semenov et al. 2004). Recent evidence also 
indicates that selective recruitment of LRP5/6 and receptor tyrosine kinases 
such as ROR1/2 and RYK, is important for WNT signaling outcome (Hendrickx 
and Leyns 2008, van Amerongen, Mikels et al. 2008). 
However, it appears that LRP5/6 cannot initiate WNT/-catenin signaling 
without the presence of FZDs (Dijksterhuis, Baljinnyam et al. 2015) and DVL is 
required for the phosphorylation of LRP6 (Bilic, Huang et al. 2007) 
1.1.5.2 ROR1/2:  
Receptor tyrosine kinase-like orphan receptor 1 and 2 (ROR 1 and ROR2) play 
an important role in neuronal development, bone formation, and in the 
development of organs such as the lungs and brain (Minami, Oishi et al. 2010). 
ROR1/2 have a similar CRD domain compared to FZD (Xu and Nusse 1998) and 
an intracellular kinase domain, which appears to be dispensable for the transfer 
to intracellular signaling cascades (Hikasa, Shibata et al. 2002). 
In case of ROR1, it is thought that WNT-5A binds to the CRD of ROR1 and then 
interacts with FZD and initiates the -catenin-independent signaling pathway. 
“Canonical” WNTs, on the other hand, were reported to antagonize ROR1 
signaling (Grumolato, Liu et al. 2010).  
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ROR1 seems to have a high potential as a diagnostic and possibly as prognostic 
marker, since it is uniformly expressed in CLL patients when compared to 
healthy individuals (Baskar, Kwong et al. 2008, Uhrmacher, Schmidt et al. 2011)  
Activation of the non-canonical JNK signaling pathway via ROR2 has been 
shown to be WNT-5A-dependent (Unterseher, Hefele et al. 2004). Further, 
overexpression experiments with ROR2 revealed an inhibitory function of this 
receptor on the -catenin dependent WNT pathway (Mikels and Nusse 2006). 
1.1.5.3 RYK: 
The receptor-like tyrosine kinase (RYK) has an extracellular N-terminal domain, 
known to bind WNT proteins (Patthy 2000), and an intracellular PDZ domain. In 
experiments with human cells, interaction with WNT-1 and WNT-3A was shown 
to be followed by the activation of the -catenin dependent WNT pathway. 
Furthermore, it has been suggested that RYK thereby forms together with FZD 
and WNT a trimeric complex that activates signal transduction via DVL (Lu, 
Yamamoto et al. 2004). 
1.1.5.4 Vangl1/2: 
Van Gogh-like protein 1 and 2 (Vangl1/2) are four-pass transmembrane 
proteins that are known to be components of the PCP pathway (Wu and 
Mlodzik 2009). Vangl2 and ROR2 are known to act together to transduce the 
signal after the binding of WNT-5A. ROR2 forms a receptor complex  with  
Vangl2  and  phosphorylates Vangl2  in  a  WNT-dependent  manner,  which  is  
subsequently  essential  for  establishing  the planar cell polarity via Rho and 
JNK (Gao, Song et al. 2011). 
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1.1.6 FZD binding partners 
FZD receptors are known to interact directly or indirectly with many proteins 
involved in WNT signaling such as LRP5/6, DVL1/2/3 and various G proteins.  
So far, it is not well described how exactly DVL interacts with FZD. Is full 
activation of the receptor leading to the binding of DVL to the receptor or does 
DVL already exist in a pre-associated state? In other words, it is still unknown 
whether the interaction between DVL and FZDs is static or dynamic and how 
agonist treatment is altering this interaction. 
This is rather difficult to analyze and study since available DVL antibodies are 
poor for detection of endogenous DVL and co-expression with FZDs recruits 
DVL to the membrane (Cong, Schweizer et al. 2004). 
The DVL protein consists of three main domains: the N terminal Dishevelled and 
Axin (DIX) domain, the Dishevelled, Eg-10 and Pleckstrin (DEP) domain and the 
Psd-95/Disc large/ZO-1 homologous (PDZ) domain. The DIX domain is the main 
domain involved in polymerization of DVL and the proteins typical punctate 
appearance when overexpressed in vitro (Schwarz-Romond, Merrifield et al. 
2005). The PDZ domain enables DVL to interact with other proteins including 
Class Frizzled receptors whereas the DEP domain is functionally involved in the 
regulation of small GTPases. DVL has been shown to be involved in the -
catenin-dependent as well as the –independent pathways such as PCP, 
WNT/RAC, WNT/RHO and possibly also the WNT/Ca2+ pathway (Gao and Chen 
2010). 
Activation of the WNT/PCP signaling pathway requires the translocation of DVL 
to the plasma membrane pointing at the importance of the cellular localization 
of DVL  (Park, Gray et al. 2005). 
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FZDs are - despite all debates - thought to interact with heterotrimeric G 
proteins. In silico analysis proposed interaction of FZDs with G proteins 
specifically of the Gαi/o, Gαq and Gαs groups (Moller, Vilo et al. 2001). In vivo 
studies showed pertussis toxin sensitive inhibition of the FZD1 mediated -
catenin-dependent WNT signaling pathway through Gαo. Additionally, WNT/β-
catenin signaling could effectively be blocked by the knockdown of Gαq proteins 
(Liu, DeCostanzo et al. 2001). Experiments using loss-of-function mutations in 
DVL, overexpression of GSK3β and the use of mutant Gαo proteins in Drosophila 
further supported the function of FZDs as guanine nucleotide exchange factors 
(GEF) and localized G protein activity upstream of DVL (Katanaev, Ponzielli et al. 
2005). 
Inhibition of the FZD2-mediated -catenin-independent signaling pathway was 
also achieved by pertussis toxin treatment and knockdown experiments of Gαo 
and Gαt2 (Liu, Liu et al. 1999, Ahumada, Slusarski et al. 2002), which supports 
the possibility of different G proteins being recruited to the same FZD 
depending on the activating signal. 
Loss-of-function approaches indicated a functional role of heterotrimeric G 
proteins in WNT/FZD signaling (Slusarski, Corces et al. 1997, Liu, Liu et al. 1999, 
Liu, Liu et al. 1999, Sheldahl, Park et al. 1999, Katanaev, Ponzielli et al. 2005, 
Koval, Purvanov et al. 2011). More recently, experiments in mammalian cells 
and tissue preparations confirmed that WNTs can evoke GDP/GTP exchange at 
heterotrimeric G proteins at physiological stoichiometry of the involved 
signaling components (Katanaev and Buestorf 2009, Kilander, Dijksterhuis et al. 
2011, Kilander, Halleskog et al. 2011, Koval, Purvanov et al. 2011, Halleskog and 
Schulte 2013). 
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Thus, even though WNT-FZD-G protein signaling is relevant in physiological 
processes, underlying details of FZD-G protein communication and its 
involvement WNT signaling remain unclear. 
With regard to the FZD co-receptor LRP6 or the similar LRP5, it is generally 
believed that binding of WNT to FZDs leads to the formation of a WNT-FZD-LRP 
complex (van Amerongen, Mikels et al. 2008). This complex formation and the 
subsequent recruitment of the scaffolding protein DVL lead to the activation of 
LRP6/5 by CK1-mediated phosphorylation. Subsequently, the activated co-
receptor causes a redistribution of Axin to the cell membrane and leaves a 
dysfunctional destruction complex in the cytosol (Stamos and Weis 2013). 
However, the underlying stoichiometry remains unclear (Schulte 2015). This 
causes β-catenin to accumulate in the cell and to enter the nucleus, where it 
binds to the transcription factors TCF/LEF and regulates the expression of a 
variety of proteins, including cyclin D1, c-myc, COX-2 and iNOS  (Ramsay, 
Ciznadija et al. 2003, Barker 2008, Du, Zhang et al. 2009, MacDonald, Tamai et 
al. 2009). It has been thus proposed that WNTs induce co-clustering of FZDs and 
DVL in LRP6-signalosomes, which in turn triggers the phosphorylation of LRP6 
and promote Axin recruitment and -catenin stabilization (Bilic, Huang et al. 
2007) 
1.1.7 Structure, function and transport 
Upon activation by extracellular agonists, GPCRs transmit signals to the cell 
interior. Ligands can bind GPCRs either on the extracellular N-terminus and 
part of the extracellular loops (for example glutamate receptors) (Niswender 
and Conn 2010) or to a well-defined binding pocket within the 
transmembrane helical bundle (Rhodopsin) (Landau, Pebay-Peyroula et al. 
2003). 
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Figure 1: Superimposing the inactive conformational structures of 
the SMO receptor (magenta) and class A GPCRs (light green) from 
the side (Wang, Wu et al. 2013) 
All GPCRs are activated 
either by agonists, or 
through a spontaneous 
auto-activation of 
receptors, referred to as 
constitutive activity 
(Trzaskowski, Latek et al. 
2012). Full activation of 
GPCRs is acquired through 
a conformational change “switching” the receptor from its inactive to its 
active state. This type of “switching” has been previously described for 
classical GPCRs. The amino acids which form the so called D(E)RY motif in 
most of the Class A GPCRs are conserved Glu, Arg and Tyr on the cytoplasmic 
end of transmembrane domain 3 (TM3) (Fahmy and Sakmar 1993). 
The Arginine is, with 96 % homology, the most conserved amino acid in Class 
A GPCRs (Mirzadegan, Benko et al. 2003). In the inactive conformation of the 
receptor, a number of hydrogen bonds are formed with the neighboring 
amino acids Glu, Glu and Thr (Ramon, Cordomi et al. 2007, Cordomi, Ramon et 
al. 2008), through which TM3 connects with TM6 and the charge of the Arg 
within the D(E)RY motif is shielded/neutralized. This network surrounded by 
the arginine is referred to as “ionic lock” (Vogel, Mahalingam et al. 2008). 
Upon stabilization of the active conformation, a proton is added to this 
network (Arnis, Fahmy et al. 1994, Knierim, Hofmann et al. 2007), de-
stabilizing the charge between the helices whereupon the side chain of the 
arginine is used as docking site for the G protein. 
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Opening of the lock is accompanied by large conformational changes of TM6 
in the agonist-G protein-bound β2 adrenergic receptor complex (Rasmussen, 
DeVree et al. 2011). However, even though the D(E)RY motif exists in almost 
all class GPCRs (Rosenbaum, Rasmussen et al. 2009), an “ionic lock” has not 
been identified in all GPCRs. The “ionic lock” in the β1-adrenergic receptor, for 
example, does not seem to have an essential role for the maintenance of the 
inactive state (Warne, Serrano-Vega et al. 2008). 
With regard to Class Frizzled receptors, which do not contain a D(E)RY motif, a 
mechanism corresponding to the “ionic lock” has so far not been identified. In 
addition, there is no crystal structure for any FZD reported so far, which makes 
it difficult to pinpoint certain amino acids that could be relevant for FZD 
activation. However, the high resolution crystal structure of the closely-related 
smoothened (SMO) receptor has previously been published (Wang, Wu et al. 
2013). 
Interestingly, when superimposing the structures of SMO and class A GPCRs, all 
receptors - despite their homology and functional differences – appear to be 
structurally quite similar (Figure 1). However, most of the conserved motifs for 
class A GPCRs are lacking and the structure reveals an unusually complex 
arrangement of long extracellular loops (Wang, Wu et al. 2013). 
With respect to FZDs, the G protein–receptor interface within the third 
intracellular loop (i3) and the C-terminus (Wess 1998) overlaps substantially 
with regions important for FZD–DVL interaction (Wong, Bourdelas et al. 2003, 
Tauriello, Jordens et al. 2012). This overlap raises the question whether steric 
hindrance or close collaboration play a role for FZD–DVL and FZD–G protein 
interaction, signal integration and signal specification. 
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1.1.8 Oligomerization 
For a long time, it was believed that GPCRs exist exclusively as monomers. 
However, in the late 90s, first oligomerization on the vasopressin V2 receptor 
(V2R) (Schoneberg, Yun et al. 1996), the gonadotropin-releasing hormone 
receptor (GnRHR) (Grosse, Schoneberg et al. 1997) and the δ- opioid receptor 
(Cvejic and Devi 1997) was shown. Since then, a vast number of GPCRs were 
shown to form oligomeric complexes. Even in tissue, where GPCRs are 
expressed endogenously, oligomerization of receptors has been detected 
(Albizu, Cottet et al. 2010). Nevertheless, how GPCR oligomerization takes place 
at the molecular level and what is the role of the oligomers in receptor function 
and pharmacology has only been resolved for a few GPCRs. For the prototype 
GPCRs, rhodopsin, β2-adrenergic- and the μ-opioid receptor, it was shown that 
a monomer is sufficient for the binding of a G protein (Ernst, Gramse et al. 
2007, Whorton, Bokoch et al. 2007, Whorton, Jastrzebska et al. 2008, Kuszak, 
Pitchiaya et al. 2009, Rasmussen, DeVree et al. 2011). In the case of rhodopsin, 
a monomer was detected as the smallest functional unit sufficient for the 
binding of -arrestin and for the phosphorylation through GRK1 (Scheerer, Park 
et al. 2008, Tsukamoto, Sinha et al. 2010, Bayburt, Vishnivetskiy et al. 2011). 
Nevertheless, it is widely assumed that the reason for an interaction between 
GPCRs is not always the activation of signal transduction itself. Rather 
cooperative and allosteric effects have been described (Nature Reviews Drug 
Discovery 2004). 
From a pharmacological point of view it is of particular interest to study the 
possibility of different signaling pathway activation via the formation of GPCR 
oligomers. 
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As an example, reduction of Gi-coupling by co-expression of δ- and μ-opioid 
receptors (George, Fan et al. 2000, Charles, Mostovskaya et al. 2003) or CCR5 
and CCR2 chemokine receptors (Mellado, Rodriguez-Frade et al. 2001) has been 
reported. With respect to homo-oligomers of the TSH-Receptor, however, both 
Gs and Gq are activated: The TSH hormone binds first to the N-terminal high-
affinity binding site on the receptor followed by Gs C-terminal coupling. When 
the low-affinity site on the N-terminus is occupied by TSH, an additional Gq 
coupling to the oligomer occurs (Allen, Neumann et al. 2011). Another 
mechanism lies in the initiation of signal transduction via transactivation within 
a GPCR dimer. Here, the ligand binds initially at the N-terminus of one receptor. 
This ligand then activates the G-protein coupling to the neighboring receptor. 
This type of activation has been shown by signal deficient mutants of the 
luteinizing hormone receptor that are only in combination capable of initiating 
a signaling cascade (Rivero-Muller, Chou et al. 2010).  
There are also GPCR oligomers described, which play an important role in their 
transport to the plasma membrane (PM) or in their internalization. 
The best known example here is the GABAB receptor that can be transported 
from the endoplasmic reticulum (ER) to the plasma membrane only as an 
oligomer. The subunit GABAB1 cannot access the plasma membrane due to a 
coat protein-complex I (COPI) binding site on the C-terminus. COPI is a protein 
complex that forms the shell of retrograde transport vesicles in the secretory 
pathway. Only after interaction with GABAB2 this binding site is hidden. While 
GABAB2 is also transported without the presence of GABAB1 to plasma 
membrane, the converse is not possible. However, both subunits of the GABA 
receptor are important for signaling: GABAB1 for ligand binding and GABAB2 for 
the G protein coupling (Pin, Comps-Agrar et al. 2009). 
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In the mentioned phenomena it is, in most cases, unclear whether the 
interacting GPCR exist only as dimers or even higher oligomers and whether 
these di- or oligomers exist in a fixed, possibly functional, stoichiometry of 
monomers and dimers (or oligomers). 
Ligand-induced rearrangement, but not dissociation, of a dimeric metabotropic 
glutamate receptor (mGluR) was linked to receptor activation (Xue, Rovira et al. 
2015), whereas for the M1 muscarinic, β1-adrenergic and GABAB receptor, 
dimer formation and dissociation of a dimer could be observed by single 
molecule tracking (Hern, Baig et al. 2010, Calebiro, Rieken et al. 2013). The 
dynamics of oligomers, however, is overall poorly studied.  
In the case of receptor tyrosine kinases an influence of the monomer-dimer 
relationship (M/D) is known for its activity (Maruyama 2014). However, such 
monomer-dimer relation in regard to GPCRs regulation has hardly been taken 
into consideration. 
1.1.9 Mechanisms of G protein activation 
The activation of G proteins requires an activated GPCR. In order to clarify the 
interplay between G protein and GPCR or in other words - how G proteins 
reach an activated receptor - I would like to introduce two different models 
which are being discussed in the field (Hein and Bunemann 2009). Receptor and 
G protein can interact by catalytic collision interaction (collision coupling) (Hein, 
Frank et al. 2005, Digby, Lober et al. 2006), which means that a single receptor 
can possibly activate multiple G proteins in succession. A collision coupling 
mechanism for the 2-adrenergic receptor (B2AR) has been demonstrated 
(Hein, Frank et al. 2005) and it has been estimated that the -adrenergic 
receptor is able to activate about 100 Gs molecules in native membranes 
(Ransnas and Insel 1988). 
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Furthermore, the 2-adrenergic receptor for example interacts with Gi via a 
collision mechanism (Hein, Frank et al. 2005). 
This mechanism explains in a more plausible way the observed signal gain on 
G protein level, where a receptor can activate more G proteins at the same 
time. The accumulation of G proteins to particular cell compartments or 
specializations of the plasma membrane furthermore favors their selective 
interactions with the receptor (Huang, Hepler et al. 1997). 
As an alternative model, varying degree of pre-coupling, pre-assembly or 
inactive-state preassembly between receptor and G protein are discussed 
(Bruheim, Krobert et al. 2003, Qin, Dong et al. 2011, Drastichova and Novotny 
2012). The pre-coupling, pre-assembly or inactive-state preassembly models 
can in part explain the specificity of a GPCR-G protein complex and the rapid 
intracellular signal response. However, the effect on signal amplification has its 
limitations when considering these types of models. Here, the so called collision 
coupling model that ensures rapid exchange of G proteins, seems to be 
necessary to provide the enormous amplification reported for example for 
rhodopsin (Oldham and Hamm 2008). 
Nevertheless, one cannot rule out the possibility that a receptor changes from 
one model to the other and therefore ensures both: rapid signaling and signal 
amplification. Signal amplification can also occur downstream of G protein 
activation. Localization of proteins in membrane signaling microdomains, such 
as caveolae and lipid rafts, can further promote one model over the other.  
In the absence of a ligand, the G alpha subunit is GDP bound and in complex 
with Gβγ. The activation of a receptor results in a high affinity binding of the 
G alpha subunit to the receptor. 
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The receptor then acts as guanine nucleotide exchange factor (GEF), thereby 
supporting the release of GDP. This is followed by the binding of GTP, which is 
present in significantly higher concentration than GDP in cells. The guanine 
nucleotide exchange results in a conformational change of the G alpha subunit, 
which either leads to the dissociation of G alpha and the Gβγ subunits or causes 
a rearrangement of these subunits (Hepler and Gilman 1992, Bunemann, Frank 
et al. 2003). Thereupon, G and also the Gβγ subunits activate downstream 
events (Ford, Skiba et al. 1998). The G subunit contains an intrinsic GTPase 
activity that hydrolyzes GTP to GDP and thus leads to the re-association of the 
G subunit with the Gβγ complex, which terminates the cycle. However, 
experiments with purified G proteins suggested that the GTPase activity is 
biochemically considered too slow to terminate physiological processes (in the 
range of 10-20 seconds for most G proteins 50 seconds for Gq and up to 
7 min for Gz (Gilman 1987, Berstein, Blank et al. 1992). This contradiction led 
to the postulation of regulatory proteins (regulators of G protein signaling 
[RGS]) accelerating the GTPase activity, which could be isolated and their 
GTPase-activating function has been demonstrated (Ross and Wilkie 2000).  
1.1.10 Ligands and G proteins 
Specific binding of a ligand to its receptor is a prerequisite for most of the drug 
effects. GPCRs can trigger a number of different signaling cascades within the 
cell after the specific binding of a particular ligand. According to their effects on 
signal transduction, ligands may be present as 1) full agonists 2) partial 
agonists 3) neutral antagonists 4) inverse agonists (Rosenbaum, Rasmussen et 
al. 2009). In addition, in recent years, biased agonism or ligand bias for GPCRs, 
has been introduced. 
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It describes the functional selectivity of a ligand (having many different 
efficacies), activating upon binding to the receptor one or several possible 
signal pathways, also referred to as "pluridimensional efficacy" (Violin and 
Lefkowitz 2007, Kenakin 2011, Whalen, Rajagopal et al. 2011, Reiter, Ahn et al. 
2012). More recent studies show that GPCRs can bypass G proteins and initiate 
G protein-independent signaling through -arrestin. Thus, they are able to act 
as agonists or inverse agonists at the same receptor and activate different 
signaling pathways (Galandrin, Oligny-Longpre et al. 2007). In the same year 
Violin and Lefkowitz confirmed that "biased-ligands" can selectively activate G 
proteins or -arrestin (Violin and Lefkowitz 2007). For the chemical compound 
JNJ7777120, for example, it was shown that it was a "biased ligand" for the 
Histamine H4 receptor that selectively activates -arrestin, independent of the 
G Protein (Rosethorne and Charlton 2011). 
In the literature, many terms for biased agonism have been used: "agonist-
directed trafficking of receptor stimulus", "Agonist trafficking of receptor 
signals" (Kenakin 1995, Berg, Maayani et al. 1998), "functional selectivity", 
"biased agonism" (Kenakin 2007), "ligand biased efficacy", "collateral efficacy", 
"pluridimensional efficacy" (Galandrin and Bouvier 2006). 
Such "biased signaling" offers many new opportunities to target and modulate 
specific signaling pathways and thus intervene with pathophysiological 
processes (Violin and Lefkowitz 2007, Kenakin 2011). 
Biased signaling in terms of WNT/FZD signaling has been proposed in a 
systematic mapping study, where distinct WNT-FZD interactions where related 
to individual signaling (Kilander, Halleskog et al. 2011, Dijksterhuis, Baljinnyam 
et al. 2015). Furthermore, there is evidence that a single FZD can activate 
multiple signaling pathways. 
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FZD3, FZD4 and FZD5 for example can act through possibly both, the -catenin 
dependent and independent WNT signaling pathway (Burns, Zhang et al. 2008). 
This is probably depending on the interaction of FZDs with downstream 
proteins or on the combination of FZDs binding to different WNTs (Mikels and 
Nusse 2006, van Amerongen, Mikels et al. 2008). 
However, the underlying mechanisms that determine the outcome of WNT-
induced FZD activation are still poorly understood. First of all, the degree of 
WNT-FZD binding specificity is largely unknown and the question if certain 
WNT-FZD combinations could selectively activate certain signaling routes over 
others has not been systematically addressed. Secondly, coupling selectivity of 
activated FZDs to downstream signaling pathways remains obscure. 
It has been shown that receptors can couple to more than one G protein 
isoform (Kenakin 1995). 
This is exemplified by the cannabinoid CB1 receptor: The ligand 
“desacetyllevonantradol” acts with respect to Gi1 and Gi2 as a positive 
agonist, however, in regard to Gi3 as an inverse agonist. “Methanandamide” is 
an inverse agonist for Gi1 and Gi2, and a positive agonist for Gi3 
(Mukhopadhyay and Howlett 2005). Corresponding observations could be 
justified by different degrees of ligand selective conformations at the receptor. 
This hypothesis, however, would be incompatible with the classic concept of 
the "two state model". 
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2 SPECIFIC AIMS 
This thesis aims to uncover new structural and functional aspects of WNT 
receptors with a strong emphasis on FZD6 and to provide a new perspective on 
molecular features of FZD in regard to the future use for drug development. 
The specific aims were in particular:  
- Solving the longstanding question of FZD-G protein coupling. 
- Obtain a more detailed and structural-function understanding of Class 
Frizzled receptors. 
- Assess FZD6 dimerization and the functional relevance of agonist 
induced dynamics 
- Role of DVL for FZD6-G protein coupling 
- Provide new tools to study FZDs for future research on Class Frizzled 
receptors 
- Develop a mammalian readout assay for the analysis of PCP protein 
activity and their asymmetric localization 
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3 MATERIALS AND METHODS 
3.1 FLUORESCENT RECOVERY AFTER PHOTOBLEACHING 
 Fluorescent recovery after photobleaching (FRAP) is a very powerful tool to 
investigate the dynamics of proteins within living cells. The method describes 
the measurement of the recovery of 
fluorescence in a defined area in a 
microscopic image after previous 
bleaching of the fluorescence in this 
particular area (Figure 2). With this 
method the mobility and diffusion rate 
of the analyzed proteins can be 
determined and analyzed. For this 
purpose, a fluorescent area is selected, 
the fluorescence intensity measured 
and then bleached by a short but strong 
laser pulse only applied at this location. 
Photobleaching is irreversibly 
destructing the fluorescent molecules, 
which is causing it to become non-
fluorescent. Subsequently, the 
intensity in the selected area is being 
followed for a certain period of time, 
usually seconds to minutes, thereby 
detecting the time it takes for fluorescent proteins to migrate into this area. 
 
Figure 2 Fluorescence intensities of a Bleached-ROI in 
a time series, the bleached area is marked red. 
Illustrated are different types of possible kinetics 
depended on the properties of the proteins. For all 
examples a region of interest (ROI) within a cell is 
bleached (red box). Non bleached molecules are 
moving into the ROI. The speed of redistribution can 
be determined  (Lippincott-Schwartz, Altan-Bonnet et 
al. 2003) 
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The gained intensity of the recovery curve is then needed to calculate the 
diffusion coefficient, from which the percentage of the mobile proteins can be 
determined (Figure 2). 
The modified dual color FRAP (dcFRAP) method is using two fluorescently 
labeled proteins allowing to study their interaction dynamics. Therefore cell 
surface or specific protein mediated cross-linking is needed (Dorsch, Klotz et al. 
2009, Lambert 2009). 
This method has been one of the main breakthroughs in Paper I, where we 
measured G protein binding to a FZD6 receptor and monitored its dissociation 
upon agonist stimulation. In addition, with the modified dcFRAP method we 
were able to look for receptor-receptor interaction and its dynamics in Paper II. 
3.2 FLUORESCENT CROSS CORRELATION SPECTROSCOPY 
To overcome the issue of overexpressing certain proteins and artificially cross 
linking the cellular 
membrane of living cells 
another method has been 
used. Fluorescent cross-
correlation spectroscopy 
(FCCS) is a very sensitive 
method with which near 
physiological relevant levels 
of receptors and proteins can 
be studied in living cells. 
 
 
Figure 3 Principle of fluorescence correlation spectroscopy: the 
fluorescence intensity originates from a well-defined volume and 
are recorded and correlated to yield estimates for the average 
number of molecules observed and the characteristic fluctuation 
time (Wenger and Rigneault 2010) 
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Fluorescence correlation spectroscopy (FCS) was developed in the early 70s by 
Elson and Webb to measure the transport properties and concentrations of 
fluorophores in solution (Bopp and Magdeburg 1972, Webb 1976) . In FCS, a 
focused laser beam illuminates a voxel in a size of a femtoliter or smaller.  
The fluorescent particles diffuse through the focus due to Brownian motion. 
The light, which is emitted by the fluorophores while they passively diffuse 
through the voxel is collected and detected using a confocal microscope. 
Since the measurements take place in a very small observation volume, FCS is 
also considered as a single-molecule technology. When a volume of one 
femtoliter is observed with a 1 nM solution less than one particle (0.6) is 
observed within the focus. An important extension of FCS is FCCS, also known 
as two-color FCS (Schwille, Meyer-Almes et al. 1997). The principle based on 
FCCS is the simultaneous excitation and detection of two spectrally separated 
fluorophores. In addition to auto-correlation for each channel, the intensity 
fluctuations of both channels can be cross-correlated. Particles, that give a 
signal simultaneously in both channels, meaning both colors simultaneously 
diffuse through the volume when they interact with each other, contribute to 
the cross-correlation (Figure 3). 
The cross-correlation amplitude provides information about the fraction 
containing two colors diffusing at the same time through the focus. A series of 
such in vitro binding studies have been conducted using the FCCS (Tewes, Tsikas 
et al. 1998) 2. 
                                                 
2
 Weidemann, T., Wachsmuth, M., Tewes, M., Rippe, K. and Langowski, J. (2002), Analysis of 
Ligand Binding by Two-Colour Fluorescence Cross-Correlation Spectroscopy. Single Mol., 3: 49–
61. doi: 10.1002/1438-5171(200204)3:1<49::AID-SIMO49>3.0.CO;2-T 
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The FCCS is an elegant, biophysical method that slowly finds its application also 
in biological and pharmacological questions. Schmidt et al. showed with the 
help of FCCS that the oligomerization of the amyloid precursor protein (APP) is 
inhibited in the presence of the transmembrane Sortilin-related receptor 
(SORLA) (Schmidt, Baum et al. 2012).  
Due to its single molecule sensitivity, this method allowed us in paper II to 
further dissect the dynamics in FZD6 dimerization without the use of artificial 
cross linking. Together with dcFRAP, FCCS has been a very powerful tool in our 
experimental setup to link and analyze receptor-receptor and receptor-G 
protein dynamics. 
3.3 CIRCULAR DICHROISM (CD) 
The CD spectroscopy is an excellent method to gain helpful indications for 
secondary structure of a protein or peptide. The term circular dichroism (CD) 
refers to the different absorption of right and left circularly polarized light 
through a sample in the Ultraviolet-Visible Spectrophotometry (UV-Vis). 
In general, protein CD spectra can be divided into two characteristic spectral 
regions: i) absorbing in a range from 160 to 230 nm, the so called peptide 
region, and ii) a range of 230 to 300 nm, in which mostly aromatic acid are 
detected and absorbed. The CD spectra of proteins in the peptide range below 
250 nm are sensitive for the detection of secondary structures. This applies in 
particular for the characterization of α-helical units (Sreerama and Woody 
2004). 
The UV-Vis CD spectrum of -helix is characterized by a positive band at 192 nm 
and by two negative minima at 208 and 222 nm. Expectedly, coiled-coils show 
in CD experiments also the typical signals for -helices. 
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While the absorption bands at 222 nm gives indications on the -helical 
content, the 208 nm absorption band is an indication that the helix exists as 
single or is present in multiform, as in coiled-coils (Lau, Taneja et al. 1984). 
In contrast to the CD spectrum of a helical structures antiparallel -sheets are 
indicated by a positive absorption band at 195 nm and a negative signal at 218 
nm (Figure 4). Typical CD spectra are detected in a range of 260-178 nm within 
30 to 60 minutes. 
 
Figure 4 Characteristic UV-Vis circular dichroism (CD) spectra of -Helix, a -sheet and a disordered 
random coil structure
3
. 
Circular dichroism in combination with isothermal titration calorimetry (see 
below) was used in paper II to validate TM minigenes as tools to interfere with 
receptor dynamics. 
3.4 THE ISOTHERMAL TITRATION CALORIMETRY 
Isothermal titration calorimetry (ITC) is used to detect interactions between 
substances of equal or different molecule classes. 
                                                 
3
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These range from interactions between two peptides, to hormone-receptor 
binding, up to interactions between antibodies and their cell surface proteins. 
ITC measurements are performed by titrations. If two binding partners interact, 
heat is produced or released from the measuring system. This depends on 
whether it is an endothermic or exothermic reaction, respectively. This heat 
change is measured and used to calculate the change in enthalpy (∆H). This 
value describes the change in the energy state of a system. In addition, by using 
titration, the calorimeter can be used to determine the affinity, or the Kd-value 
of the interacting partners (Freyer and Lewis 2008). 
3.5 CELLULAR THERMAL SHIFT ASSAY 
The folding of a protein is often stabilized by binding of other molecules. The 
stabilization is manifested among others by increased thermal stability of the 
protein in which the biological activity of the protein is retained even at 
relatively high temperatures and denaturion starts only at higher temperatures 
(Koshland 1958). The novel cellular thermal shift assay (CETSA) is very simple 
and requires no labeling with dyes compared to the previous known thermal 
shift assay (Niesen, Berglund et al. 2007). The CETSA method is most commonly 
used to measure the thermal stability for a given protein at different 
temperatures, with and without the presence of an active ingredient. The 
heating in this case takes just about a minute. When an active ingredient binds, 
the thermal stability of the protein is changing. This is referred to the melting 
curve (Martinez Molina, Jafari et al. 2013, Jafari, Almqvist et al. 2014). We have 
used this method in Paper III to compare the thermal shift of FZD6-wt receptors 
compared to the mutant form thought to be influencing the conformation and 
therefore the thermal stability of the protein.  
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4 RESULTS AND DISCUSSION 
4.1 FZD6-G PROTEIN INTERACTION: COLLISION COUPLING VS INACTIVE 
STATE ASSEMBLY AND G PROTEIN SELECTIVITY 
Functional interaction of ligand, GPCR and the heterotrimeric G proteins as 
transducers was summarized in the so called ternary complex model, which 
describes the receptor-dependent allosteric interaction of ligand and G proteins 
(De Lean, Stadel et al. 1980). However, as mentioned in the introduction 
controversy still exists concerning whether GPCRs are pre-assembled/pre-
coupled with heterotrimeric G proteins or if the GPCR–G protein interaction is 
based on random collision in the membrane (Neubig 1994, Oldham and Hamm 
2008). Experimental evidence for all scenarios have been obtained (Hein, Frank 
et al. 2005, Nobles, Benians et al. 2005, Gales, Van Durm et al. 2006, Qin, Dong 
et al. 2011). Collision coupling postulates receptor–G proteins interaction only 
upon receptor activation. Pre-assembly of inactive GPCRs with G proteins, 
however, more readily explains receptor–G protein selectivity as well as the 
rapid responses observed in cells (Oldham and Hamm 2008).  
Along this line, I would like to make a clear difference between the term pre-
coupling and pre-assembly. Unfortunately, these semantic distinctions are not 
universally applied or understood. Many scientists would not make a 
distinction between these modes of interaction. Nevertheless, all terms 
describe, to my understanding, the direct interaction of a G protein with its 
receptor. Just the degree of interaction might be distinguishable by using the 
different terms.  Pre-coupling in this regard refers to an interaction of the G 
protein with an activated receptor (agonist activated or constitutive active), in 
which the G protein is about to become activated. 
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Pre-assembly or inactive-state-assembly refer to the interaction of an inactive 
receptor with an inactive G protein. Upon activation of the receptor, one 
might refer again to a pre-coupling. In general, a full activation of a receptor 
might look like this: 
Inactive-state-assembly/Pre-assembly -> pre-coupling -> coupling -> signaling 
-> dissociation -> Inactive-state-assemble/pre-assemble 
If, how and to what extent DVL plays a role in the context of FZD-G protein 
interaction has neither been addressed nor even touched. 
4.2 BIFUNCTIONAL ROLE OF DISHEVELLED 
Even though FZDs consist of seven trans-membrane domains and according to 
the International Union of Basic and Clinical Pharmacology belong to the group 
of GPCRs, it is still a matter of debate if FZDs indeed signal through G proteins 
and if their capability of G protein coupling has any physiological relevance.  
The first work (paper I) in this thesis solved the longstanding problem of FZD-G 
protein coupling. A suitable approach to investigate the pre-assembly or 
inactive-state-assemble of G proteins and GPCRs is the FRAP method (see 
materials and methods). FRAP permits the determination of whether GPCR and 
G protein are separated in the membrane or already paired in the inactive 
state. This method has already been used to investigate the interaction of β-
adrenergic receptors (Dorsch, Klotz et al. 2009), and recently the association of 
inactive M3 acetylcholine receptors and Gq proteins were detected (Qin, Dong 
et al. 2011).  
By performing dcFRAP experiments, we showed that FZD6 is in an inactive-
state-assembly with Gi1 and Gq proteins. 
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This interaction could be disturbed by ADP-ribosylation of adenylate cyclase by 
pertussis toxin (in the case 
of Gi1) and WNT-5A 
stimulation according to 
the ternary complex 
model. In addition, a 
pathogenic C terminal 
FZD6 Arg511Cys mutation 
known to cause nail 
dysplasia in human 
(Frojmark, Schuster et al. 2011) did not show any interaction with Gi1 or Gq. 
In regard to the scaffold protein DVL, both receptors (wt and Arg511Cys) were 
interacting with DVL when overexpressed assessed by dcFRAP.  
To further dissect this newly discovered FZD-G protein interaction, we used 
cellular imaging in combination with FRAP and Förster resonance energy 
transfer (FRET) and identified DVL as a regulator of G protein signaling. 
Modulating DVL levels by either overexpression or siRNA resulted in the loss of 
Gi1 and Gq inactive-state-assembly to FZD6 (Figure 5). This phenomenon has 
been further explored in cells expressing endogenous levels of FZDs and the 
same modulation of DVL levels, functionally impairing WNT-induced and G 
protein-dependent signaling through P-ERK1/2. 
By using different DVL3 deletion constructs we further defined specific domains 
in this newly discovered dual role of DVL as a master regulator of FZD6-G 
protein interaction (Figure 6). 
Figure 5 Gαi1 and Gαq protein coupling efficiency from dcFRAP 
experiments (left axis) was correlated with DVL3 expression levels 
(right axis) in panDVL siRNA-treated HEK293 cells, normal HEK293 
cells and in cells transfected with DVL3-FLAG (individual dcFRAP 
data for FZD6-Gαi1 and -Gαq coupling with overexpression of DVL1, 
2, 3 or panDVL siRNA treatment are presented in Paper 2. 
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Figure 6 Domain mapping using deletion mutants of FLAG-tagged DVL3 identifies the DIX domain to 
be important for the negative regulation of FZD-G protein inactive-state-assemble upon overexpression. 
 
Based on our data and what is known from classical GPCRs, we proposed in this 
study a higher order complex model integrating the function of WNT/FZD/DVL 
and heterotrimeric G proteins. This complex model was further analyzed in 
paper II. Overall, the results in paper I shed light on underlying mechanisms of 
WNT/FZD signaling specification and add new concepts on the role of 
heterotrimeric G proteins and the scaffold protein DVL for WNT/FZD signaling. 
We provided novel insight into previously unappreciated mechanisms with 
potential impact on the field of biology of WNT-based cellular communication, 
WNT/FZD pharmacology and WNT/FZD signal transduction. These data could 
have further importance for the understanding of FZD transduction in 
embryonic development, cancer and for the future development of FZD-
targeting drugs. 
We used the same technique to address inactive-state-assembly of FZD4 and 
FZD10 and G proteins. 
In the case of FZD4, G12 and G13 turned out to be the G proteins able to 
bind to the receptor whereas FZD10 seemed to be exclusively interacting in an 
inactive-state-assembly fashion with G13 (unpublished data). This also 
supports the selectivity and sensitivity of the method. 
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4.3 DYNAMIC DIMERIZATION OF FZD6 
Following up on the results from Paper I, we were interested in the 
stoichiometry underlying the balance between G protein and DVL coupling to 
FZD6. In theory, a receptor dimer 
would be necessary to 
accommodate the binding proteins 
(DVL and G protein proposed in 
paper I) due to space limitations. 
With the help of computational 
protein modeling using the closely 
related Smoothened (SMO) 
structure (Wang, Wu et al. 2013), 
we were able to model a 
homodimer of FZD6, which pointed 
to a TM4/TM5 dimer interface. The 
presented dimer model was 
complemented by dcFRAP and FCCS 
experiments in combination with site directed mutagenesis to identify a TM4/5 
interface homo-dimer of FZD6. 
Interestingly, according to a recent publication, this interface is also the one 
that most likely accomplishes G protein activation compared to dimers with a 
TM1/TM1, TM5/6 and TM4/4 interface (Cordomi, Navarro et al. 2015). 
According to the Cordomi et al. model, the open conformation of the -helical 
domain of the G protein, observed in the crystal structure of the β2AR-Gs 
complex, would sterically clash with the second protomer of a TM4/5 dimer 
(Figure 7). 
Figure 7 Hypothetical models of a TM4/5 GPCR 
dimer complex incorporating a G protein (Cordomi, 
Navarro et al. 2015). 
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One possible explanation for this 
would be that the conformation of 
the -helical domain observed in 
the β2-adrenergic receptors -Gs 
crystal might be under 
physiological conditions smaller in 
size. Though, in this study we 
provided another possible 
mechanism, which has been 
previously been unrecognized: 
dynamic, agonist-induced 
dissociation of FZD6 dimer. 
In the case of FZD6, agonist (WNT-
5A) stimulation led to the receptor 
dissociation of the dimer and G 
protein-dependent signaling 
through P-ERK1/2 was induced 
(Figure 8). This novel concept in 
GPCR receptor activation characterized by the agonist-induced, transient 
dissociation and re-association of a GPCR dimer, has not been shown previously 
(Figure 9), provides however, another mode of activation and the possibility to 
incorporate two FZD6, a G protein and DVL without the sterically clash as 
mentioned above. 
The bifunctional role of DVL as described in Paper I appears to have no 
influence on the formation of a FZD6 homo dimer assessed by modulating DVL 
levels by either overexpression or siRNA. 
Figure 8 The dcFRAP assay in HEK293 cell expressing V5-
FZD6-Cherry and FZD6-GFP allowed kinetic monitoring of 
receptor-receptor interactions upon WNT-5A addition 
(300 ng/ml). Mobile fractions were measured in the 
absence of agonist (0 min) and after 5, 10, 15, 20 min of 
WNT-5A stimulation. The transient increase of the FZD6-
GFP mobile fraction at 5-10 min indicates decreased 
dimer formation. Error bars give s.e.m.; each bar 
represents 30-40 ROIs of 8-10 different experiments. (b) 
Dynamic FCCS experiments were performed to confirm 
the dynamic and agonist-dependent nature of the FZD6 
dimer. (c) Based on the data we suggest a kinetic model 
of FZD6 de- and re-dimerization upon WNT-5A 
stimulation. 
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This suggests that FZD6 dimerization is rather receptor intrinsic and does not 
require further binding partners. Next, we related the kinetics of FZD6 
dissociation/re-association with agonist-induced signaling to ERK1/2.  
 
Figure 9: GPCR receptor activation characterized by the agonist-induced, transient dissociation and re-
association of a GPCR dimer. 
Genome editing of FZD6 expression level and modification of the proposed 
dimer using expression of FZD6 derived TM5 minigenes led to a decrease of 
basal P-ERK1/2 in mouse lung epithelial (MLE) cells, endogenously expressing 
FZD6. However, with respect to the aformentioned minigenes, it is important to 
mention that our experimental data provide evidence for an inactive state-
dimer, which is disrupted by the TM5 minigenes and kept inactive through 
possibly negative allosteric binding to TM5 peptide. 
Furthermore, WNT-5A stimulation of MLE cells led to a time-dependent 
induction of P-ERK1/2 matching the dynamics in dimerization we obtained with 
dcFRAP and FCCS supporting the idea of receptor dissociation playing a role in 
signal initiation. Overall, in this study we proposed a novel mechanism for GPCR 
activation induced by WNT-5A stimulation of FZD6. 
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Our findings shed light on the molecular mechanisms underlying GPCR/FZD 
complex composition, stoichiometry and dynamics and offer insight into the 
kinetics of WNT/FZD signal initiation. We further provide evidence for the 
physiological relevance of FZD6 dimerization in lung epithelial cells by employing 
dimer-interfering minigenes in cells that endogenously express FZD6 (paper II). 
Therefore, targeting the dimer interface to impede with receptor activation in 
vivo, might offer novel therapeutic possibilities. This study, in combination with 
paper III, provides in addition evidence that the monomeric FZD6 is inducing 
signaling and that the interaction of TM5 with monomeric wt FZD6 maintains an 
inactive state possibly through action as a negative allosteric modulator (NAM). 
Therfore, depending on the application, maintaining the dimer will promote a 
functional inactive receptor complex and interfering with the dimer interface 
can – depending on the mode of action - promote monomeric (active) FZD6 or 
monomeric (inactive) FZD6 as shown for the  TM5 minigenes. 
4.4 THE MISSING ELEMENT IN WNT/FZD SIGNALING 
Overall, the identification of the bifunctional role of DVL as crucial and 
negatively regulating factor for FZD-G protein inactive-state-assembly (paper I) 
together with the underlying dynamics in FZD6 activation (paper II) might 
explain (i) previous difficulties to mechanistically identify FZD-G protein 
coupling of FZDs and (ii) the unclear data on the involvement of G proteins and 
DVL as well as their relative localization to each other in several cellular systems 
(Liu, Rubin et al. 2005). Nevertheless, claiming that DVL is the missing link 
between G protein coupling and FZDs would be an oversimplification. It is 
important to mention that researchers have struggled to characterize FZDs to 
the same degree as other GPCRs for which structures and robust signaling 
readouts are available. 
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One of the more recent publications claims that the DVL-associating protein 
Daple (homolog of GIV/Girdin) is a guanine nucleotide exchange factor (GEF), 
which was suggested to serve as the missing factor in FZD signaling through G 
proteins (Aznar, Midde et al. 2015). While I find the idea of a non-receptor GEF 
appealing, the study was unable to provide sufficient evidence proving that 
Daple is as effective in activating heterotrimeric G protein as GPCRs are. 
However, according to the study Daple is “trapping” DVL to the cytoplasm and 
competes for FZD binding at the plasma membrane. In regard to the 
bifunctional role of DVL one might speculate that a delicate balance of DVL, 
Daple and G protein might be required for full activation of Class Frizzled 
receptors. Nonetheless, taken the bifunctional role of DVL into account, it 
seems oversimplifed to generalize this to the entire FZD receptor family, since 
FZD4 and FZD10 for example, did not show an altered G protein coupling when 
DVL was knocked down or overexpressed (unpublished data). 
4.5 STRUCTURAL ANALYSIS AND DISCOVERY OF A MOLECULAR SWITCH 
Molecular modelling of FZD6, using the recently published high resolution 
Smoothened structure as a template, identified a potentially interesting residue 
that could have implications for receptor activation. This residue FZD6-R416 is 
located in TM6 and likely forms hydrogen bonds with W493 and W495 located 
in TM7.  
Site directed mutagenesis of this particular residue resulted in a receptor with 
high internalization dynamics and intrinsic constitutive activity with regard to 
the positive regulation of G protein-dependent activation of mitogen-activated 
protein kinases (MAPK) and the inhibition of -catenin-dependent WNT 
signaling. Most interestingly, this residue – or an alternative basic residue such 
as Lys in case of FZD4 and FZD9 – is conserved among almost all Class Frizzled 
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receptors and mining of available mutational data of different patient-derived 
tumors revealed mutations in that residue in various FZDs with high frequency 
in many forms of cancer (Figure 10). Detailed analysis of the internalization of 
FZD6-R416A argues that the internalized receptor localizes to RAB5-positive 
endosomes and lysotracker-positive lysosomes. In depth analysis of the 
constitutive activity of the receptor suggests a central role of heterotrimeric G 
proteins in signaling to the MAPK pathway and in the inhibition of the WNT/-
catenin pathway. Furthermore, FZD6-R416A leads to a reduction in basal LRP6 
phosphorylation and DVL2 shift as shown by western blotting.  
Overall one might speculate that the identified basic residue R presents a 
general molecular switch among Class Frizzled receptors. 
In order to obtain a proof-of-principle and the general importance of the R416A 
constitutive activity, we extrapolated our findings to FZD10 also generating a 
constitutively active variant of this receptor isoform, negatively regulating -
catenin activation and reducing the DVL shift. The findings in this study provide 
unique insight into the WNT-induced molecular activation mechanisms of FZDs. 
Figure 10 a) homology model of FZD6 based on the high resolution crystallographic structure of SMO. 
R416
6.33
  (IC tip of TM6) is conserved in all human FZD’s except FZD4 & FZD9 (Lys) b) R416 in FZD6 is 
mutated frequently in bladder and uterine cancers. 
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Further, we uncover central and well conserved mechanisms - similar to what is 
known as the "ionic lock" in Class A GPCRs - that could provide molecular 
mechanisms for the development of many different forms of cancer. Especially 
in regard to the frequency R416 is mutated in cancer (Figure 10) and the strong 
internalization phenotype, it could provide a suitable platform for high 
throughput screening. 
So far, we have not succeeded in identifying the factor involved in the 
observed negative regulatory effect of FZD6 on -catenin (paper III).  Though 
purely speculative, together with the accumulating evidence that the Hippo 
pathway might be regulating the WNT/FZD pathway through G12/13 and Gq 
(Hergovich and Hemmings 2010, Varelas, Miller et al. 2010, Imajo, Miyatake et 
al. 2012, Kim and Jho 2014, Wang, Ye et al. 2014, Park, Kim et al. 2015), which 
in turn is regulating DVL, might give a plausible explanation in regard to the 
negative regulation of -catening through FZD6. 
4.6 MONITORING ACTIVITY OF THE WNT/PLANAR CELL POLARITY 
PATHWAY 
So far this thesis has focused mainly on the G protein signaling aspect of 
WNT/FZD signaling. However, as mentioned earlier, the WNT/FZD pathway is 
divided into several different signaling branches. Cell polarization is a 
prerequisite for the control of cell shape, directional migration, asymmetric cell 
division and function of cells within complex tissues. 
One of the key pathways, which control cell polarity, is the WNT/PCP pathway. 
WNT/PCP controls migration and cell polarity during development of all 
multicellular organisms from cnidarians to human. The function of the 
mammalian WNT/PCP machinery is still poorly understood and progress is 
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hampered mostly by experimental barriers and limitations of non-mammalian 
experimental models. 
A recent report showed that the WNT/PCP pathway is driving the pathogenesis 
of chronic lymphocytic leukemia (CLL).  It was shown that PCP pathway key 
components such as Vangl2, Celsr1, Prickle1, FZD3, FZD7, DVL2, DVL3, and 
casein kinase 1 (CK1)-ε are 
upregulated in B 
lymphocytes of patients 
with CLL (Kaucka, Plevova 
et al. 2013). Most 
interestingly, in this study, 
it was shown that patient-
derived B-cells, expressing 
to a higher extend FZD3, 
FZD7 and Prickle1, had a 
less favorable prognosis 
(Kaucka, Plevova et al. 
2013). In the last paper of 
this thesis (paper IV), we 
used the well characterized 
CLL cell line MEC1 to develop a useful and powerful model for studying PCP and 
CLL behavior in vitro, which can easily be manipulated. It is for example, ideal 
for high throughput screening of chemical compounds targeting mammalian 
PCP signaling. We demonstrate that several PCP proteins are asymmetrically 
localized in migrating MEC1 cells (Figure 11). 
Figure 11 Subcellular localization of fluorescently-tagged PCP 
proteins in polarized MEC1 cells. (A) Photomicrograph of 
migrating polarized MEC1 cell with precisely defined leading and 
trailing edge. Vangl2-EGFP is significantly enriched in the trailing 
edge of the cell. To visualize the cytoskeleton, actin-RFP was co-
transfected with the Vangl2 construct. Arrow indicates the 
direction of migration. Size bar = 10 μm. (B, C, D) Polarized 
structure of migrating MEC1 cells expressing ROR2-mCherry, 
DVL3-EYFP and β-arrestin 2. Arrows indicate the direction of cell 
migration. Size bars = 10 μm. 
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This is similar to the localization of PCP protein observed in Drosophila wing or 
eye where polarized localization of PCP proteins serves as a useful readout of 
PCP pathway activity (McNeill 2010). 
By correlating asymmetric localization of fluorescently-tagged PCP proteins 
such as Vangl2 with MEC1 cell migration and chemotaxis, we showed that 
casein kinase 1 maintains the polarized localization of Vangl2 in the trailing 
edge and at the same time is required for directed cell migration (paper IV). 
Despite this, the highlight of this story is that for the first time clear polarization 
of PCP proteins could be observed in vitro in cells that are not embedded in 
tissue, and lack permanent cell-cell contact. 
This work defines a long–awaited mammalian cell-based readout for analysis of 
activity and asymmetric localization of PCP proteins, which was so far limited to 
the powerful, but evolutionary distant, Drosophila system. The novel assay 
developed in this study opens for the first time possibilities to study 
mammalian PCP signaling in a cell culture assay. Moreover, the assay can be 
easily automated, which allows the design of screens aimed at identification of 
novel PCP pathway components and PCP pathway-targeting drugs. 
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5 GENERAL DISCUSSION AND FUTURE PERSPECTIVES 
Class Frizzled and Class A receptors share many common aspects and at the 
same time show substantial diversity. They share very similar structural 
features (Figure 1) and all couple to heterotrimeric G proteins (Dijksterhuis, 
Petersen et al. 2014, Kilander, Petersen et al. 2014). Nevertherless, it is still a 
matter of debate if Class Frizzled receptors are indeed GPCRs and if a 
physiological relevance lies behind the observed coupling to heterotrimeric G 
proteins. However, this thesis provides not only possible new, previously 
unappreciated mechanisms through which FZDs signal but also novel 
explanations why it is so diffiult to study this unconventional type of GPCR. 
Despite the novel structural and functional aspects of WNT 
receptors provided in this thesis, the view on FZDs is diversely discussed in the 
field and multiple pathways and numerous factors supporting or disrupting 
signaling have been proposed (see introduction). Here, we propose a higher 
order complex consisting of two FZD6 incorporating one DVL and a 
heterotrimeric G protein. This however, needs to be elucidated in more detail 
to reveal the exact stoichiometry between receptor, DVL and G proteins and 
the underlying ligand-induced dynamics. Furthermore, we concluded that in the 
case of FZD6 a dimeric receptor is required to form a functional inactive 
receptor complex and, once activated, the monomeric FZD6 induces signaling. 
In this context, numerous studies have shown that activation of GPCRs and G 
proteins does not necessarily require the binding of a ligand to the receptor 
(Robinson, Cohen et al. 1992, Porter, Hwa et al. 1996, Kenakin 2001, Seifert and 
Wenzel-Seifert 2002). This is referred to as constitutive activity, where a 
receptor activates G proteins in the absence of agonists. 
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Also mutations in the receptor (Alewijnse, Timmerman et al. 2000, Clark, Dever 
et al. 2004) and truncation of the third intracellular loop & the c-terminus can 
cause constitutive activity (Boone, Davis et al. 1993, Lefkowitz, Cotecchia et al. 
1993, Paavola, Stephenson et al. 2011). Constitutive activity has not been 
addressed for FZDs yet. In this thesis, we provide the first evidence that FZD6-wt 
has intrinsic constitutive activity when overexpressed. A dynamic equilibrium 
between inactive dimers and potentially active monomers is present (paper II) 
and that mutations in TM6 increase ERK1/2 signaling through FZD6 (paper III). 
Though highly speculative, FZD6-R416A could be a biased (constitutive active) 
mutant. Since we propose a FZD6-wt dimer consisting of one DVL and one 
G protein, one might speculate that FZD6 can activate either DVL or G protein 
related signaling depending on the activation of the receptor. In this regard, the 
FZD6-R416A would be “biased” towards G protein signaling since it has no effect 
on DVL and induces agonist-independent ERK1/2 signaling. This theory is 
supported by the fact, that the FZD6-R416A mutant neither co-localizes with 
DVL2-GFP nor induces DVL2 shift in HEK293 cells. Furthermore, the negative 
effect that was observed on LRP6 phosphorylation could be explained by the 
lack of DVL interaction with FZD6 which might have important implications for 
signaling. DVL was shown to be required for LRP6 phosphorylation and 
aggregation (Bilic, Huang et al. 2007). 
In addition, it would be interesting to investigate the mechanisms through 
which DVL affects stoichiometry of FZD complexes. In other words, why is DVL 
required for the interaction between FZD6 and G-proteins, but not a necessary 
component for FZD6 dimer formation? Does DVL induce a particular 
conformational change to achieve G protein binding? 
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Or is DVL promoting the recruitment of, for example, Daple to act as a GEF? 
Furthermore, it is unclear if DVL is required for the receptor dynamics observed 
in paper II. 
Future studies will offer new insight into Class Frizzled receptors 
and provide researchers with pharmacological tools to target them. To gain an 
even deeper and more detailed understanding of FZDs, it would be of great 
importance to define the smallest functional unit in regard to FZD activation 
as it was shown for rhodopsin (Tsukamoto, Sinha et al. 2010, Bayburt, 
Vishnivetskiy et al. 2011). This however, requires purification and reconstitution 
of FZDs into so called HDL particles. The potential of such particles would be 
immense. The aforementioned stoichometry can not only be better defined 
but also the role of DVL, Daple, LRP5/6 and other proteins can be elucidated 
using GTPS binding studies. Furthermore, WNT selectivity can be addressed 
in a new and more physiological fashion, which is so far restricted to CRD 
binding studies. 
Using dcFRAP or the mentioned HDL-particles in combination with FZDs 
lacking the WNT-binding domain, could also further answer the question if 
receptor dimerization is a prerequisite for ligand binding and if one WNT is 
sufficient to activate one or possible both receptors and if this is dependent on 
different WNT/FZD combination? 
From the drug developmental point of view and the connection 
between impaired WNT signaling and various diseases, FZDs are a very 
attractive target for drug therapy. There are however, several complicating 
factors for drug development, most notably the lack of assays to monitor WNT-
FZD interaction or direct FZD activation.  
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The establishment of an HTS assay for FZDs has also been hampered because 
coupling of a detectable tag to WNTs affects its biological activity, which is 
important for the binding and activation to FZDs. Another complicating factor is 
the lack of small molecule agonists or antagonists for FZDs. Development of 
agonist and antagonist as potential treatment for diseases targeting conditions 
with downregulated versus overexpressed WNT-signaling is of great 
significance (Schulte 2010). 
The development of selective drugs targeting GPCRs is challenging due to 
several reasons i) there is a high degree of homology among many closely 
related receptor subtypes that can regulate diverse physiologic function ii) a 
single receptor can couple to different G proteins and initiate even G protein-
independent pathways iii) a receptor can allosterically be influenced by 
receptor homo-dimers or hetero-dimers and iv) signaling behavior of GPCRs 
might differ dependent on different cells or organs (Trzaskowski, Latek et al. 
2012). 
The improved understanding of signal transduction initiated by FZDs provided 
in this thesis could reveal new mechanisms suitable as targets for new drugs. 
Furthermore, the techniques employed in papers I, II and IV could open up new 
avenues for high throughput screening assays for the development of small 
molecules targeting WNT receptors. 
In summary, the functional studies described in this thesis are 
mostly incompatible with the classic concept of the two-state equilibrium 
model of GPCR activation. 
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A multistate model would be more appropriate, where ligands can stabilize 
specific conformations or subsets of activities (Deupi and Kobilka 2010) making 
the complexity of GPCR signaling similar to the microprocessor work4. 
 
                                                 
4
 Kenakin T. In: GPCR Molecular Pharmacology and Drug Targeting. Shifting Paradigms and New 
Directions. Gilchrist A, editor. John Wiley & Sons: John Wiley Sons. Hoboken; 2010. pp. 1–26. 
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6 CONCLUSION 
 
Paper I 
- FZD6 can couple to Gi1 and Gq 
- WNT-5A stimulation leads to the dissociation of Gi1 and Gq in a time 
dependent manner 
- A pathogenic C terminal FZD6 Arg511Cys mutation known to cause nail 
dysplasia in human does not interact with Gi1 or Gq. 
- Inactive-state-assembly is dependent on a delicate balance of DVL 
Paper II 
- FZD6 dimerizes through a TM4/5 interface 
- Agonist stimulation results in the transient dissociation of the FZD6 dimer 
- Dimeric FZD6 is inactive, wheras upon activation FZD6 becomes monomeric 
and initiates signaling 
- Kinetics of FZD6 dissociation/re-association coincide with agonist-induced 
signaling to ERK1/2 
- Genome editing and expression of FZD6-derived TM5 minigenes interfered 
with FZD6-dependent signaling to ERK1/2 in lung epithelial cells 
Paper III 
- Identification of a molecular switch in TM6/7 of FZD6 
- The FZD6-R416A mutant (molecular switch) negatively regulates the -catenin 
pathway and activates G protein-dependent ERK1/2 signaling 
- Gq activation appears to be relevant for the inhibitory effect of -catenin 
- R416 in FZD6 is frequently mutated in bladder and uterine cancer 
- The molecular switch seems to be a general feature of activation in Class FZD 
receptors 
Paper IV 
- MEC1 cells are a suitable screening model for chronic lymphocytic leukemia 
- Clear polarization of fluorecently tagged PCP proteins observed in a unicellular 
context 
- PCP proteins,  such as Vangl2-EGFP, serves as a useful readout of PCP pathway 
activity 
- Casein kinase 1 maintains polarized localization of Vangl2 in the trailing edge 
and at the same time is required for directed cell migration 
- Polarization of Vangl2 is independent of an intact actin cytoskeleton 
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